日盈電子(603286.SH):公司電子皮膚靈巧手的整手解決方案增加了手掌/手背/手指側面的檢測區域
格隆匯6月16日丨日盈電子(603286.SH)在投資者互動平台表示,公司目前第一代電子皮膚產品系壓阻式方案,主要能感知到温度、壓力,公司的壓阻式方案不僅可以應用於人形機器人靈巧手指尖,也可以應用於靈巧手整手,公司電子皮膚靈巧手的整手解決方案增加了手掌/手背/手指側面的檢測區域,整手有上千個接觸點(包含温度、壓力),同時具有曲面覆蓋的特點、能實現手指曲面的檢測。由於人形機器人處於早期發展階段,下游客户的產品技術方案、實際市場需求以及量產時間、規模、價格等方面均存在不確定性,目前公司電子皮膚產品對公司業績不形成影響,公司特別提醒廣大投資者理性決策,審慎投資,注意相關風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.